GuiZhou SanLi Pharmaceutical Co.,Ltd

Shanghai Stock Exchange 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd Market Capitalization on January 27, 2025: USD 724.37 M

GuiZhou SanLi Pharmaceutical Co.,Ltd Market Capitalization is USD 724.37 M on January 27, 2025, a -24.26% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

GuiZhou SanLi Pharmaceutical Co.,Ltd 52-week high Market Capitalization is USD 1.01 B on March 18, 2024, which is 39.44% above the current Market Capitalization.
GuiZhou SanLi Pharmaceutical Co.,Ltd 52-week low Market Capitalization is USD 625.06 M on August 23, 2024, which is -13.71% below the current Market Capitalization.
GuiZhou SanLi Pharmaceutical Co.,Ltd average Market Capitalization for the last 52 weeks is USD 793.77 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd

CEO	Mr. Hai Zhang
IPO Date	April 28, 2020
Location	China
Headquarters	Xiayun Industrial Park
Employees	2,282
Sector	Health Care
Industries Pharmaceuticals

Description

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.

Key trends

Past 5 years